Genomewide analysis of inherited variation associated with phosphorylation of PI3K/AKT/mTOR signaling proteins

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Hutz, Janna E ^a,b   Manning, W Aaron ^a   Province, Michael A ^b   McLeod, Howard L ^a  

^a University of North Carolina   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE; EIF4EBP1 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TARGET OF RAPAMYCIN KINASE;

AKT1 GENE; ARTICLE; CHROMOSOME 14; CHROMOSOME 3; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GRM7 GENE; HEREDITY; HSP90AA1 GENE; HUMAN; HUMAN CELL; HUMAN GENOME; INHERITANCE; LYMPHOBLASTOID CELL LINE; PHENOTYPE; PROTEIN FAMILY; RAF1 GENE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; METABOLISM; PHOSPHORYLATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CHROMOSOMES, HUMAN, PAIR 3; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 80052876461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024873     Document Type: Article

References (52)

1. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336.
2. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
3. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
4. Jansen RC, Nap JP, (2001) Genetical genomics: the added value from segregation. Trends Genet 17: 388-391.
5. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, et al. (2003) Genetics of gene expression surveyed in maize, mouse and man. Nature 422: 297-302.
6. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, et al. (2009) A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41: 527-534.
7. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105-116.
8. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371: 1505-1512.
9. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42: 142-148.
10. Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L, et al. (2009) Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 84: 388-398.
11. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, et al. (2005) Mapping determinants of human gene expression by regional and genome-wide association. Nature 437: 1365-1369.
12. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, et al. (2004) Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 75: 1094-1105.
13. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743-747.
14. Huang RS, Duan S, Kistner EO, Bleibel WK, Delaney SM, et al. (2008) Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res 68: 3161-3168.
15. Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME, (2008) Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther 7: 3038-3046.
16. Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, et al. (2010) Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 20: 1482-1492.
17. Calafell F, Almasy L, Sabater-Lleal M, Buil A, Mordillo C, et al. (2010) Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels. Hum Mol Genet 19: 517-525.
18. He M, Cornelis MC, Kraft P, van Dam RM, Sun Q, et al. (2010) Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels. Arterioscler Thromb Vasc Biol 30: 885-890.
19. Maier T, Guell M, Serrano L, (2009) Correlation of mRNA and protein in complex biological samples. FEBS Lett 583: 3966-3973.
20. Sun Q, Cornelis MC, Kraft P, Qi L, van Dam RM, et al. (2010) Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels. Hum Mol Genet.
21. Garge N, Pan H, Rowland MD, Cargile BJ, Zhang X, et al. (2010) Identification of quantitative trait loci underlying proteome variation in human lymphoblastoid cells. Mol Cell Proteomics 9: 1383-1399.
22. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4: e1000072.
23. Carracedo A, Pandolfi PP, (2008) The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27: 5527-5541.
24. Hawkins PT, Anderson KE, Davidson K, Stephens LR, (2006) Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 34: 647-662.
25. Liu P, Cheng H, Roberts TM, Zhao JJ, (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
26. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, et al. (2001) Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17: 615-675.
27. Franke TF, (2008) PI3K/Akt: getting it right matters. Oncogene 27: 6473-6488.
28. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB, (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
29. Alessi DR, Pearce LR, Garcia-Martinez JM, (2009) New insights into mTOR signaling: mTORC2 and beyond. Sci Signal 2: pe27.
30. Corradetti MN, Guan KL, (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347-6360.
31. Garcia-Echeverria C, Sellers WR, (2008) Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27: 5511-5526.
32. Guertin DA, Sabatini DM, (2007) Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
33. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA, (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137.
34. Karege F, Perroud N, Schurhoff F, Meary A, Marillier G, et al. (2010) Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav.
35. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, et al. (2005) Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58: 446-450.
36. Blumenthal GM, Dennis PA, (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet 16: 1289-1300.
37. Kumar A, Wolpert C, Kandt RS, Segal J, Pufky J, et al. (1995) A de novo frame-shift mutation in the tuberin gene. Hum Mol Genet 4: 1471-1472.
38. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, et al. (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808.
39. Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, et al. (2009) Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol 27: 857-871.
40. Hutz JE, Kraja AT, McLeod HL, Province MA, (2008) CANDID: a flexible method for prioritizing candidate genes for complex human traits. Genet Epidemiol 32: 779-790.
41. Huang S, Ballard D, Zhao H, (2007) The role of heritability in mapping expression quantitative trait loci. BMC Proc 1 (Suppl 1): S86.
42. Pilia G, Chen WM, Scuteri A, Orru M, Albai G, et al. (2006) Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2: e132.
43. Yuan X, Waterworth D, Perry JR, Lim N, Song K, et al. (2008) Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 83: 520-528.
44. Greenwood TA, Cadman PE, Stridsberg M, Nguyen S, Taupenot L, et al. (2004) Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans. Physiol Genomics 18: 119-127.
45. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, et al. (2008) Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4: e1000282.
46. Liao Y, Hung MC, (2010) Physiological regulation of Akt activity and stability. Am J Transl Res 2: 19-42.
47. Sato S, Fujita N, Tsuruo T, (2000) Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci U S A 97: 10832-10837.
48. Gao Z, Garcia-Echeverria C, Jensen MR, (2010) Hsp90 inhibitors: clinical development and future opportunities in oncology therapy. Curr Opin Drug Discov Devel 13: 193-202.
49. Massey AJ, Schoepfer J, Brough PA, Brueggen J, Chene P, et al. (2010) Preclinical antitumor activity of the orally available heat shock protein 90 inhibitor NVP-BEP800. Mol Cancer Ther 9: 906-919.
50. Kiyatkin A, Aksamitiene E, Markevich NI, Borisov NM, Hoek JB, et al. (2006) Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops. J Biol Chem 281: 19925-19938.
51. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, et al. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286: 1738-1741.
52. Yu CF, Liu ZX, Cantley LG, (2002) ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 277: 19382-19388.